EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Management of Adverse Effects of Endocrine Therapy in Early‐Stage Breast Cancer: Pharmacological and Nonpharmacological Approaches

Timothy B Winslow iD, Alissa Huston, Ruth O'Regan, Susan Dent

Clinical Endocrinology · 18.08.2025

DOI: 10.1111/cen.70011 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Clinical Endocrinology, online erschienen am 18.08.2025. Verfasst von Timothy B Winslow und 3 weiteren Autor:innen. Beteiligte Einrichtung: Division of Hematology/Oncology, Department of Medicine & Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, New York, USA. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 53 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Over 70% of breast cancers are hormone receptor positive and endocrine therapy (i.e., aromatase inhibitors and tamoxifen) is considered standard of care. Side effects from endocrine therapy can be significant for patients leading to early treatment discontinuation. As adjuvant endocrine therapy is typically recommended for 5–10 years, proactively addressing adverse effects is important to facilitate patient compliance. This review addresses the common adverse effects of adjuvant endocrine therapy in early‐stage breast cancer and approaches to management including both pharmacologic and non‐pharmacologic strategies.

Conclusion

There are multiple pharmacologic and non‐pharmacologic management strategies available to alleviate side effects from endocrine therapy in patients with hormone receptor positive early stage breast cancer. Non‐pharmacologic management strategies may be underutilized and should be considered early in the management of endocrine therapy adverse effects.

Schlagwörter

Stichwörter der Autor:innen

adverse effect managementbreast cancerendocrine therapyintegrative oncology

Autor:innen und Institutionen

  • Division of Hematology/Oncology, Department of Medicine & Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, New York, USA.

ORCID-Profile: Timothy B Winslow

Zitieren

APA

Winslow, T. B., Huston, A., O'Regan, R., & Dent, S. (2025). Management of Adverse Effects of Endocrine Therapy in Early‐Stage Breast Cancer: Pharmacological and Nonpharmacological Approaches. Clinical Endocrinology. https://doi.org/10.1111/cen.70011

Vancouver

Winslow TB, Huston A, O'Regan R, Dent S. Management of Adverse Effects of Endocrine Therapy in Early‐Stage Breast Cancer: Pharmacological and Nonpharmacological Approaches. Clinical Endocrinology. 2025. doi:10.1111/cen.70011

BibTeX
@article{Winslow2025,
  author = {Winslow, Timothy B and Huston, Alissa and O'Regan, Ruth and Dent, Susan},
  title = {Management of Adverse Effects of Endocrine Therapy in Early‐Stage Breast Cancer: Pharmacological and Nonpharmacological Approaches},
  journal = {Clinical Endocrinology},
  year = {2025},
  doi = {10.1111/cen.70011}
}
Kostenlos starten →